{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:14:11Z","timestamp":1775754851663,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11886-016-0750-9","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T08:29:30Z","timestamp":1466065770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bioresorbable Stents in PCI"],"prefix":"10.1007","volume":"18","author":[{"given":"Daniel","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"issue":"8058","key":"750_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","volume":"1","author":"A Gr\u00fcntzig","year":"1978","unstructured":"Gr\u00fcntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1(8058):263.","journal-title":"Lancet"},{"issue":"10","key":"750_CR2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrcardio.2011.96","volume":"8","author":"O Yousuf","year":"2011","unstructured":"Yousuf O, Bhatt DL. The evolution of antiplatelet therapy in cardiovascular disease. Nat Rev Cardiol. 2011;8(10):547\u201359.","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"750_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","volume":"316","author":"U Sigwart","year":"1987","unstructured":"Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701\u20136.","journal-title":"N Engl J Med"},{"issue":"8","key":"750_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","volume":"331","author":"PW Serruys","year":"1994","unstructured":"Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331(8):489\u201395.","journal-title":"N Engl J Med"},{"issue":"15","key":"750_CR5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","volume":"344","author":"PW Serruys","year":"2001","unstructured":"Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Sch\u00f6nberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344(15):1117\u201324.","journal-title":"N Engl J Med"},{"issue":"3","key":"750_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221\u201331.","journal-title":"N Engl J Med"},{"issue":"23","key":"750_CR7","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"M-C Morice","year":"2002","unstructured":"Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773\u201380.","journal-title":"N Engl J Med"},{"issue":"9591","key":"750_CR8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","volume":"370","author":"C Stettler","year":"2007","unstructured":"Stettler C, Wandel S, Allemann S, Kastrati A, Morice M-C, Sch\u00f6mig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370(9591):937\u201348.","journal-title":"Lancet"},{"issue":"10","key":"750_CR9","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","volume":"356","author":"B Lagerqvist","year":"2007","unstructured":"Lagerqvist B, James SK, Stenestrand U, Lindb\u00e4ck J, Nilsson T, Wallentin L, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356(10):1009\u201319.","journal-title":"N Engl J Med"},{"issue":"9562","key":"750_CR10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667\u201378.","journal-title":"Lancet"},{"issue":"10","key":"750_CR11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","volume":"356","author":"GW Stone","year":"2007","unstructured":"Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice M-C, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356(10):998\u20131008.","journal-title":"N Engl J Med"},{"issue":"23","key":"750_CR12","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","volume":"125","author":"S Bangalore","year":"2012","unstructured":"Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012;125(23):2873\u201391. Lippincott Williams & Wilkins.","journal-title":"Circulation"},{"issue":"1","key":"750_CR13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2014.04.022","volume":"64","author":"G Sarno","year":"2014","unstructured":"Sarno G, Lagerqvist B, Nilsson J, Fr\u00f6bert O, Hambraeus K, Varenhorst C, et al. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR. J Am Coll Cardiol. 2014;64(1):16\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"750_CR14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.115.019071","volume":"133","author":"M Taniwaki","year":"2016","unstructured":"Taniwaki M, Radu MD, Zaugg S, Amabile N, Garc\u00eda-Garc\u00eda HM, Yamaji K, et al. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation. 2016;133(7):650\u201360. Lippincott Williams & Wilkins.","journal-title":"Circulation"},{"issue":"18","key":"750_CR15","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","volume":"115","author":"S Cook","year":"2007","unstructured":"Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426\u201334. Lippincott Williams & Wilkins.","journal-title":"Circulation"},{"issue":"1","key":"750_CR16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193\u2013202.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"750_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","volume":"129","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation. 2014;129(2):211\u201323. Lippincott Williams & Wilkins.","journal-title":"Circulation"},{"issue":"2","key":"750_CR18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehi571","volume":"27","author":"SH Hofma","year":"2006","unstructured":"Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27(2):166\u201370. The Oxford University Press.","journal-title":"Eur Heart J"},{"issue":"3","key":"750_CR19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCINTERVENTIONS.108.797928","volume":"1","author":"M Hamilos","year":"2008","unstructured":"Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N, et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv. 2008;1(3):193\u2013200.","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"750_CR20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.110.957332","volume":"4","author":"SO Marx","year":"2011","unstructured":"Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv. 2011;4(1):104\u201311. Lippincott Williams & Wilkins.","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"750_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10554-010-9769-y","volume":"28","author":"G Sarno","year":"2012","unstructured":"Sarno G, Bruining N, Onuma Y, Garg S, Brugaletta S, De Winter S, et al. Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial. Int J Cardiovasc Imaging. 2012;28(1):51\u20138. Springer Netherlands.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"9616","key":"750_CR22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","volume":"371","author":"JA Ormiston","year":"2008","unstructured":"Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MWI, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371(9616):899\u2013907.","journal-title":"Lancet"},{"issue":"20","key":"750_CR23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jacc.2008.08.024","volume":"52","author":"S Tanimoto","year":"2008","unstructured":"Tanimoto S, Bruining N, van Domburg RT, Rotger D, Radeva P, Ligthart JM, et al. Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology. J Am Coll Cardiol. 2008;52(20):1616\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"750_CR24","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.110.970772","volume":"122","author":"PW Serruys","year":"2010","unstructured":"Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301\u201312. Lippincott Williams & Wilkins.","journal-title":"Circulation"},{"issue":"3","key":"750_CR25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","volume":"7","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Pacheco E, Perkins LEL, Lane JP, Wang Q, Kamberi M, et al. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model. Circ Cardiovasc Interv. 2014;7(3):330\u201342. Lippincott Williams & Wilkins.","journal-title":"Circ Cardiovasc Interv"},{"issue":"9962","key":"750_CR26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"PW Serruys","year":"2015","unstructured":"Serruys PW, Chevalier B, Dudek D, Cequier \u00c1, Carri\u00e9 D, I\u00f1iguez A, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet. 2015;385(9962):43\u201354.","journal-title":"Lancet"},{"key":"750_CR27","unstructured":"Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, et al. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med. 2015 Oct 12. This trial randomized 2008 patients to Absorb or DES and represents the largest trial comparing bioresorbable stents with DES."},{"issue":"21","key":"750_CR28","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","volume":"66","author":"R Gao","year":"2015","unstructured":"Gao R, Yang Y, Han Y, Huo Y, Chen J, Yu B, et al. Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China trial. J Am Coll Cardiol. 2015;66(21):2298\u2013309.","journal-title":"J Am Coll Cardiol"},{"issue":"47","key":"750_CR29","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","volume":"36","author":"T Kimura","year":"2015","unstructured":"Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, et al. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36(47):3332\u201342. The Oxford University Press.","journal-title":"Eur Heart J"},{"key":"750_CR30","doi-asserted-by":"crossref","unstructured":"Stone GW, Gao R, Kimura T, Kereiakes DJ, Ellis SG, Onuma Y, et al. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis. Lancet. 2016;387(10025):1277\u201389.","DOI":"10.1016\/S0140-6736(15)01039-9"},{"key":"750_CR31","doi-asserted-by":"crossref","unstructured":"Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet. 2015;387(10018):537\u201344.","DOI":"10.1016\/S0140-6736(15)00979-4"},{"issue":"8","key":"750_CR32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","volume":"65","author":"S Puricel","year":"2015","unstructured":"Puricel S, Arroyo D, Corpataux N, Baeriswyl G, Lehmann S, Kallinikou Z, et al. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. J Am Coll Cardiol. 2015;65(8):791\u2013801.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"750_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","volume":"37","author":"M Sabat\u00e9","year":"2016","unstructured":"Sabat\u00e9 M, Windecker S, I\u00f1iguez A, Okkels-Jensen L, Cequier A, Brugaletta S, et al. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial. Eur Heart J. 2016;37(3):229\u201340. The Oxford University Press.","journal-title":"Eur Heart J"},{"issue":"1","key":"750_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2015.09.024","volume":"9","author":"MJ Lipinski","year":"2016","unstructured":"Lipinski MJ, Escarcega RO, Baker NC, Benn HA, Gaglia MA, Torguson R, et al. Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2016;9(1):12\u201324. This is the to date largest meta-analysis comparing bioresorbable stents with DES.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"750_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcin.2013.07.007","volume":"7","author":"S Verheye","year":"2014","unstructured":"Verheye S, Ormiston JA, Stewart J, Webster M, Sanidas E, Costa R, et al. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. JACC Cardiovasc Interv. 2014;7(1):89\u201399.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"750_CR36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jcin.2008.09.015","volume":"2","author":"R Waksman","year":"2009","unstructured":"Waksman R, Erbel R, Di Mario C, Bartunek J, de Bruyne B, Eberli FR, et al. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. JACC Cardiovasc Interv. 2009;2(4):312\u201320.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"750_CR37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4244\/JV4I4A82","volume":"4","author":"G Ghimire","year":"2009","unstructured":"Ghimire G, Spiro J, Kharbanda R, Roughton M, Barlis P, Mason M, et al. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention. 2009;4(4):481\u20134.","journal-title":"EuroIntervention"},{"issue":"9869","key":"750_CR38","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)61765-6","volume":"381","author":"M Haude","year":"2013","unstructured":"Haude M, Erbel R, Erne P, Verheye S, Degen H, B\u00f6se D, et al. Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet. 2013;381(9869):836\u201344.","journal-title":"Lancet"},{"issue":"10013","key":"750_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","volume":"387","author":"M Haude","year":"2016","unstructured":"Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, et al. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. Lancet. 2016;387(10013):31\u20139.","journal-title":"Lancet"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0750-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-016-0750-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0750-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:28:28Z","timestamp":1498321708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-016-0750-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1007\/s11886-016-0750-9","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]},"article-number":"74"}}